Becton, Dickinson and Company (BDX) Holdings Reduced by California Public Employees Retirement System

California Public Employees Retirement System trimmed its position in Becton, Dickinson and Company (NYSE:BDX) by 0.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 523,124 shares of the medical instruments supplier’s stock after selling 684 shares during the quarter. California Public Employees Retirement System owned about 0.23% of Becton, Dickinson and worth $102,506,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the company. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in Becton, Dickinson and by 55.8% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock worth $131,000 after acquiring an additional 240 shares in the last quarter. Parkside Financial Bank & Trust grew its position in Becton, Dickinson and by 8.1% in the second quarter. Parkside Financial Bank & Trust now owns 684 shares of the medical instruments supplier’s stock worth $133,000 after acquiring an additional 51 shares in the last quarter. Harfst & Associates Inc. grew its position in Becton, Dickinson and by 46.4% in the second quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier’s stock worth $135,000 after acquiring an additional 221 shares in the last quarter. Harvest Fund Management Co. Ltd grew its position in Becton, Dickinson and by 82.8% in the second quarter. Harvest Fund Management Co. Ltd now owns 746 shares of the medical instruments supplier’s stock worth $146,000 after acquiring an additional 338 shares in the last quarter. Finally, Acrospire Investment Management LLC grew its position in Becton, Dickinson and by 259.7% in the second quarter. Acrospire Investment Management LLC now owns 831 shares of the medical instruments supplier’s stock worth $162,000 after acquiring an additional 600 shares in the last quarter. 88.60% of the stock is currently owned by hedge funds and other institutional investors.

Several research analysts have issued reports on the company. Zacks Investment Research upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $234.00 target price for the company in a research report on Tuesday, October 31st. Piper Jaffray Companies restated a “buy” rating and set a $213.00 target price on shares of Becton, Dickinson and in a research report on Tuesday, September 12th. BidaskClub upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating in a research report on Monday, August 14th. Cowen restated a “buy” rating and set a $230.00 target price on shares of Becton, Dickinson and in a research report on Monday, August 14th. Finally, Wells Fargo & Company assumed coverage on Becton, Dickinson and in a research report on Friday, September 22nd. They set an “outperform” rating and a $225.00 target price for the company. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $217.08.

Shares of Becton, Dickinson and Company (BDX) opened at $218.31 on Tuesday. The company has a debt-to-equity ratio of 1.44, a quick ratio of 5.03 and a current ratio of 5.58. Becton, Dickinson and Company has a 12 month low of $161.50 and a 12 month high of $229.68. The firm has a market cap of $50,082.27, a P/E ratio of 23.15, a PEG ratio of 1.72 and a beta of 1.07.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings data on Thursday, November 2nd. The medical instruments supplier reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $2.37 by $0.03. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.14 billion. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 20.56%. Becton, Dickinson and’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.12 earnings per share. sell-side analysts expect that Becton, Dickinson and Company will post 10.63 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 8th will be paid a $0.75 dividend. This is an increase from Becton, Dickinson and’s previous quarterly dividend of $0.73. The ex-dividend date is Thursday, December 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.37%. Becton, Dickinson and’s payout ratio is 64.52%.

COPYRIGHT VIOLATION WARNING: This piece of content was first reported by Week Herald and is the sole property of of Week Herald. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://weekherald.com/2017/12/12/becton-dickinson-and-company-bdx-holdings-reduced-by-california-public-employees-retirement-system.html.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply